z-logo
open-access-imgOpen Access
CYP24A1 variant modifies the association between use of oestrogen plus progestogen therapy and colorectal cancer risk
Author(s) -
Xabier García-Albéniz,
Anja Rudolph,
Carolyn M. Hutter,
Emily White,
Yi Lin,
Stephanie A. Rosse,
Jane C. Figueiredo,
Tabitha A. Harrison,
Shuo Jiao,
Hermann Brenner,
Graham Casey,
Thomas J. Hudson,
Mark Thornquist,
Loı̈c Le Marchand,
John D. Potter,
Martha L. Slattery,
Brent W. Zanke,
John A. Baron,
Bette J. Caan,
Stephen J. Chanock,
Sonja I. Berndt,
Deanna L. Stelling,
Charles S. Fuchs,
Michael Hoffmeister,
Katja Butterbach,
Mengmeng Du,
W. James Gauderman,
Marc J. Gunter,
Mathieu Lemire,
Shuji Ogino,
Jennifer S Lin,
Richard B. Hayes,
Robert W. Haile,
Robert E. Schoen,
Greg S. Warnick,
Mark A. Jenkins,
Stephen N. Thibodeau,
Fredrick R. Schumacher,
Noralane M. Lindor,
Laurence N. Kolonel,
John L. Hopper,
Jian Ping Gong,
Daniela Seminara,
Bethann M. Pflugeisen,
Cornelia M. Ulrich,
Conghui Qu,
David Duggan,
Michelle Cotterchio,
Peter T. Campbell,
Christopher S. Carlson,
Polly A. Newcomb,
Edward Giovannucci,
Li Hsu,
Andrew T. Chan,
Annette Peters,
Jenny ChangClaude
Publication year - 2016
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/14mj-1p71
Subject(s) - progestogen , cyp24a1 , colorectal cancer , medicine , oncology , cancer , estrogen , vitamin d and neurology , calcitriol receptor

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here